Lack of CD9 in mice that develop spontaneous prostate cancer mirrors the former human studies, namely, CD9 deficiency increased liver metastases, although it had no effect on onset of primary tumors, nor on lung metastases (30). The gene discussed is CD9; the disease is prostate carcinoma.